# pharma_cdmo_industry_heir Consistency Adversarial 3pass Audit

Date: 2026-05-02
Status: PASS
Work ID: `pharma_cdmo_industry_heir`
Scope: Phase0 / work_guard / source TR / root BI / audit trail / material_ssot registry consistency after immediate-deployment promotion

## Executive Verdict

The BI/TR pair is complete and internally consistent.

- TR B001-B070: `complete`
- root BI: `exists`
- BI/TR pair: `complete`
- source TR gate: `PASS`
- BI 5-pass: `PASS`
- GREENPLUS benchmark: `PASS`
- immediate deployment overlay: `PASS`
- registry status: `GREENPLUS`, `immediate_deployable_material`, `adopted_and_recorded`
- remaining blocking issue: `none`

## Pass 1 - Authority And Stage Surface Attack

Attack:

- active material-side authority may disagree about whether the pair is complete
- registry, alias, work-index, and status files may point to different states
- immediate-deployment claim may be present in one place but absent in the governing surfaces

Result: `PASS`.

Evidence:

- `treatments/preprocess/pharma_cdmo_industry_heir/sequential_run_status.json`
  - `last_sequential_block_pass=70`
  - `source_tr_gate_status=PASS`
  - `bi_status=PASS`
  - `benchmark_alias=GREENPLUS`
  - `material_deployment_status=immediate_deployable_material`
- `material_ssot/00_governance/production-pair-operational-registry-v1.json`
  - row exists for `pharma_cdmo_industry_heir`
  - `benchmark_alias=GREENPLUS`
  - `benchmark_freshness=current`
  - `material_deployment_status=immediate_deployable_material`
  - `donor_structure_status=adopted_and_recorded`
- alias file exists:
  - `material_ssot/00_governance/production_pair_grade_aliases/GREENPLUS_pharma_cdmo_industry_heir.md`
- work-index files exist:
  - `material_ssot/50_tr/work-index/pharma_cdmo_industry_heir.md`
  - `material_ssot/60_bi/work-index/pharma_cdmo_industry_heir.md`
- root material README immediate deployment list includes `pharma_cdmo_industry_heir`

Judgment:

No active authority surface still claims BI is missing, source gate is pending, or the work is merely reference inventory.

## Pass 2 - Phase0 / work_guard / TR / BI Contract Attack

Attack:

- BI may have been invented independently rather than synchronized
- TR may drift from Phase0 or work_guard rules
- source TR may pass basic parse but fail production-pair normalization
- plot_roadmap may not be hash-synchronized to the live TR

Result: `PASS`.

Evidence:

- BI 5-pass rerun result: `PASS`
- `production_pair_normalization_runner` result:
  - pair_consumability: `pass`
  - strict_tier_a_status: `pass`
  - tier_b_status: `normalized`
  - schema_status: `pass`
  - evidence_mode: `serialized_canonical`
  - open_migration_debt: `false`
  - active_baseline_eligible: `true`
  - required_fix_targets: `[]`
- source TR metrics remain clean:
  - production_density_gate: `PASS`
  - hard_gate_failures: `[]`
  - diegetic_meta_ref_count: `0`
  - label_meta_ref_count: `0`
  - npc_continuity_mismatch_count: `0`
  - stable opponent.name: `70/70`
- `MasterBible.plot_roadmap` is synchronized from the root source TR.
- `genre_ext.block_cider.has_cider=true`: `70/70`
- `genre_ext.reader_payoff_ladder`: `70/70`

Judgment:

BI is a deterministic pair artifact, not a separate story invention. TR and BI share the same 70-block source truth.

## Pass 3 - Donor / Contamination / GREENPLUS Claim Attack

Attack:

- immediate-deployment status may be overclaimed without donor decision visibility
- donor material may contaminate pharma/CDMO canon
- GREENPLUS may rely on schema cleanliness rather than opening conversion and reward cadence
- protagonist may be efficient but not legibly successful or supportable

Result: `PASS`.

Evidence:

- donor decision is visible in `treatments/preprocess/pharma_cdmo_industry_heir/source_manifest.json`
  - decision: `adopted`
  - scope: proof -> receipt -> authority/access asset -> next gate cadence
  - blocked surfaces: donor proper nouns/skins, 착한 공장 미담, 신약 shortcut
- work_guard forbids:
  - 신약 천재 shortcut
  - GMP/CDMO 전문어 장식화
  - 대가 없는 선의
  - reward 없는 pain-only block
- GREENPLUS benchmark report confirms:
  - P0: `6/6`
  - P1: `20/20`
  - full-block cider: `70/70`
  - opening pacing: `GREEN`
  - whole-run pacing: `GREEN`
- immediate deployment closeout confirms:
  - donor structure adopted and recorded
  - contamination guardrails visible
  - pair-level usability tied to donorized structure, not alias prestige
- protagonist success is rights/control based:
  - 품질문서 원본
  - 품질책임자 대행권
  - 병원 구매실 직통선
  - 글로벌 CDMO audit ticket
  - 데이터 escrow/audit log fee
  - 국가 산업 표준 운영 컨소시엄 의장권

Judgment:

The work is not coasting on a GREENPLUS label. The opening conversion, blockwise reward cadence, donor review, contamination guardrails, and registry closure all point to the same operational reading.

## Final Closeout

Consistency verdict: `PASS`.

Allowed current reading:

- `pharma_cdmo_industry_heir` is a completed BI/TR pair.
- It is a current `GREENPLUS` material-side pair.
- It is admitted as `immediate_deployable_material`.
- No B071, BI reinvention, or manuscript packet was created in this unit.
- Next work should be a separate downstream prose/packet order, not more root TR/BI production.

Confidence: `97/100`.
